MX2021000326A - Desoxirribosa-fosfato aldolasas modificadas geneticamente. - Google Patents
Desoxirribosa-fosfato aldolasas modificadas geneticamente.Info
- Publication number
- MX2021000326A MX2021000326A MX2021000326A MX2021000326A MX2021000326A MX 2021000326 A MX2021000326 A MX 2021000326A MX 2021000326 A MX2021000326 A MX 2021000326A MX 2021000326 A MX2021000326 A MX 2021000326A MX 2021000326 A MX2021000326 A MX 2021000326A
- Authority
- MX
- Mexico
- Prior art keywords
- engineered deoxyribose
- phosphate aldolases
- phosphate
- deoxyribose
- aldolases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/02—Aldehyde-lyases (4.1.2)
- C12Y401/02004—Deoxyribose-phosphate aldolase (4.1.2.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente invención proporciona polipéptidos de desoxirribosa-fosfato aldolasa modificada genéticamente útiles en condiciones de procedimientos industriales para la producción de compuestos químicos finos y farmacéuticos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862695520P | 2018-07-09 | 2018-07-09 | |
US201962822273P | 2019-03-22 | 2019-03-22 | |
PCT/US2019/040369 WO2020014048A1 (en) | 2018-07-09 | 2019-07-02 | Engineered deoxyribose-phosphate aldolases |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021000326A true MX2021000326A (es) | 2021-03-25 |
Family
ID=69101203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021000326A MX2021000326A (es) | 2018-07-09 | 2019-07-02 | Desoxirribosa-fosfato aldolasas modificadas geneticamente. |
Country Status (11)
Country | Link |
---|---|
US (3) | US11274286B2 (es) |
EP (1) | EP3821015A4 (es) |
JP (1) | JP7462969B2 (es) |
KR (1) | KR20210032417A (es) |
CN (1) | CN112673105A (es) |
AU (1) | AU2019300836A1 (es) |
CA (1) | CA3103721A1 (es) |
IL (1) | IL279882A (es) |
MX (1) | MX2021000326A (es) |
SG (1) | SG11202012107RA (es) |
WO (1) | WO2020014048A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112021000202B1 (pt) * | 2018-07-09 | 2023-03-28 | Merck Sharp & Dohme Llc | Métodos para síntese enzimática de nucleosídeo 4'-etinila 2-desóxi e compostos |
US11274286B2 (en) | 2018-07-09 | 2022-03-15 | Codexis, Inc. | Engineered deoxyribose-phosphate aldolases |
BR112021014576A2 (pt) | 2019-01-25 | 2021-10-05 | Brown University | Composições e métodos para tratamento, prevenção ou reversão de inflamação e distúrbios associados à idade |
KR20240008455A (ko) * | 2022-07-11 | 2024-01-19 | 대상 주식회사 | L-글루탐산을 생산하는 코리네박테리움 속 변이 미생물 및 이를 이용한 l-글루탐산의 생산 방법 |
Family Cites Families (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1338400C (en) | 1983-08-31 | 1996-06-18 | David H. Gelfand | Recombinant fungal cellulases |
US5308854A (en) | 1990-06-18 | 1994-05-03 | Merck & Co., Inc. | Inhibitors of HIV reverse transcriptase |
US5527819A (en) | 1991-09-06 | 1996-06-18 | Merck & Co., Inc. | Inhibitors of HIV reverse transcriptase |
US5928905A (en) | 1995-04-18 | 1999-07-27 | Glaxo Group Limited | End-complementary polymerase reaction |
US6406855B1 (en) | 1994-02-17 | 2002-06-18 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US6995017B1 (en) | 1994-02-17 | 2006-02-07 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6395547B1 (en) | 1994-02-17 | 2002-05-28 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6309883B1 (en) | 1994-02-17 | 2001-10-30 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US6165793A (en) | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US5834252A (en) | 1995-04-18 | 1998-11-10 | Glaxo Group Limited | End-complementary polymerase reaction |
US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US20060257890A1 (en) | 1996-05-20 | 2006-11-16 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
AU694954B2 (en) | 1994-06-03 | 1998-08-06 | Novo Nordisk A/S | Purified myceliophthora laccases and nucleic acids encoding same |
WO1996000787A1 (en) | 1994-06-30 | 1996-01-11 | Novo Nordisk Biotech, Inc. | Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein |
FI104465B (fi) | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
US6096548A (en) | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
US6506602B1 (en) | 1996-03-25 | 2003-01-14 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
WO1998031816A1 (en) | 1997-01-17 | 1998-07-23 | Regents Of The University Of Minnesota | Dna molecules and protein displaying improved triazine compound degrading ability |
US6326204B1 (en) | 1997-01-17 | 2001-12-04 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
AU743305C (en) | 1997-01-17 | 2006-03-30 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
US7148054B2 (en) | 1997-01-17 | 2006-12-12 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
JP3712255B2 (ja) | 1997-12-08 | 2005-11-02 | カリフォルニア・インスティチュート・オブ・テクノロジー | ポリヌクレオチドおよびポリペプチド配列を生成するための方法 |
JP2002510506A (ja) | 1998-04-02 | 2002-04-09 | テラス ジェネティック リソーシズ,インコーポレイティド | 遺伝子配列に遺伝障害を有する植物を得る方法 |
AU747190B2 (en) | 1998-05-01 | 2002-05-09 | Maxygen, Inc. | "Optimization of pest resistance genes using DNA shuffling" |
JP2002517995A (ja) | 1998-06-17 | 2002-06-25 | マキシジェン, インコーポレイテッド | 所望の特性を有するポリヌクレオチドを生成するための方法 |
US6365408B1 (en) | 1998-06-19 | 2002-04-02 | Maxygen, Inc. | Methods of evolving a polynucleotides by mutagenesis and recombination |
AU5347999A (en) | 1998-08-12 | 2000-03-06 | Maxygen, Inc. | Dna shuffling of monooxygenase genes for production of industrial chemicals |
DE69922978T2 (de) | 1998-10-06 | 2005-12-08 | Emalfarb, Mark Aaron, Jupiter | Transformationsystem in filamentösen fungiziden chrysosporium-wirtszellen |
CA2345203A1 (en) | 1998-10-07 | 2000-04-13 | Maxygen Inc. | Dna shuffling to produce nucleic acids for mycotoxin detoxification |
EP1129184A1 (en) | 1998-11-10 | 2001-09-05 | Maxygen, Inc. | Modified adp-glucose pyrophosphorylase for improvement and optimation of plant phenotypes |
JP4221100B2 (ja) | 1999-01-13 | 2009-02-12 | エルピーダメモリ株式会社 | 半導体装置 |
US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US6917882B2 (en) | 1999-01-19 | 2005-07-12 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
US6436675B1 (en) | 1999-09-28 | 2002-08-20 | Maxygen, Inc. | Use of codon-varied oligonucleotide synthesis for synthetic shuffling |
US6368861B1 (en) | 1999-01-19 | 2002-04-09 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US8457903B1 (en) | 1999-01-19 | 2013-06-04 | Codexis Mayflower Holdings, Llc | Method and/or apparatus for determining codons |
US7702464B1 (en) | 2001-08-21 | 2010-04-20 | Maxygen, Inc. | Method and apparatus for codon determining |
US7024312B1 (en) | 1999-01-19 | 2006-04-04 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
US6961664B2 (en) | 1999-01-19 | 2005-11-01 | Maxygen | Methods of populating data structures for use in evolutionary simulations |
US20070065838A1 (en) | 1999-01-19 | 2007-03-22 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US7873477B1 (en) | 2001-08-21 | 2011-01-18 | Codexis Mayflower Holdings, Llc | Method and system using systematically varied data libraries |
ES2341217T3 (es) | 1999-01-19 | 2010-06-17 | Maxygen, Inc. | Recombinacion de acidos nucleicos mediada por oligonucleotidos. |
IL144657A0 (en) | 1999-02-11 | 2002-06-30 | Maxygen Inc | High throughput mass spectrometry |
US6365377B1 (en) | 1999-03-05 | 2002-04-02 | Maxygen, Inc. | Recombination of insertion modified nucleic acids |
US6703240B1 (en) | 1999-04-13 | 2004-03-09 | Maxygar, Inc. | Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes |
US7430477B2 (en) | 1999-10-12 | 2008-09-30 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
US6519065B1 (en) | 1999-11-05 | 2003-02-11 | Jds Fitel Inc. | Chromatic dispersion compensation device |
US6686515B1 (en) | 1999-11-23 | 2004-02-03 | Maxygen, Inc. | Homologous recombination in plants |
IL150291A0 (en) | 2000-01-11 | 2002-12-01 | Maxygen Inc | Integrated systems and methods for diversity generation and screening |
WO2001075767A2 (en) | 2000-03-30 | 2001-10-11 | Maxygen, Inc. | In silico cross-over site selection |
DE60144145D1 (de) | 2000-04-03 | 2011-04-14 | Maxygen Inc | Subtilisin-variante |
JP4058665B2 (ja) | 2001-03-02 | 2008-03-12 | 有機合成薬品工業株式会社 | 2−デオキシリボース5−リン酸の製造方法 |
US20050084907A1 (en) | 2002-03-01 | 2005-04-21 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
US7747391B2 (en) | 2002-03-01 | 2010-06-29 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
EP2278509B1 (en) | 2002-03-01 | 2014-11-19 | Codexis Mayflower Holdings, LLC | Methods, systems, and software for identifying functional biomolecules |
US7620500B2 (en) | 2002-03-09 | 2009-11-17 | Maxygen, Inc. | Optimization of crossover points for directed evolution |
EP1625223A4 (en) | 2002-09-20 | 2009-11-11 | Verenium Corp | CHEMOENZYMATIC PROCEDURES FOR SYNTHESIS OF STATINES AND STATIN INTERCONNECTIONS |
US7629157B2 (en) | 2003-08-11 | 2009-12-08 | Codexis, Inc. | Ketoreductase polypeptides and related polynucleotides |
WO2005118794A2 (en) * | 2004-06-04 | 2005-12-15 | Dsm Ip Assets B.V. | Improved 2-deoxy-d-ribose 5-phosphate aldolases (deras) and the uses thereof |
WO2007132461A2 (en) * | 2006-05-11 | 2007-11-22 | Ramot At Tel Aviv University Ltd. | Classification of protein sequences and uses of classified proteins |
WO2008143679A2 (en) | 2006-06-01 | 2008-11-27 | Verenium Corporation | Nucleic acids and proteins and methods for making and using them |
WO2009008908A2 (en) | 2007-02-12 | 2009-01-15 | Codexis, Inc. | Structure-activity relationships |
EP2250594B1 (en) | 2008-02-12 | 2017-04-19 | Codexis, Inc. | Method of generating an optimized, diverse population of variants |
EP2250595B1 (en) | 2008-02-12 | 2017-06-14 | Codexis, Inc. | Method of selecting an optimized diverse population of variants |
CN102066561B (zh) | 2008-06-13 | 2013-09-25 | 科德克希思公司 | 合成多核苷酸变体的方法 |
US20090312196A1 (en) | 2008-06-13 | 2009-12-17 | Codexis, Inc. | Method of synthesizing polynucleotide variants |
US8383346B2 (en) | 2008-06-13 | 2013-02-26 | Codexis, Inc. | Combined automated parallel synthesis of polynucleotide variants |
WO2013003290A1 (en) | 2011-06-28 | 2013-01-03 | Codexis, Inc. | Protein variant generation by region shuffling |
EP2723763A4 (en) | 2011-06-24 | 2015-02-18 | Merck Sharp & Dohme | IMMOBILIZED TRANSAMINASES AND METHODS OF MAKING AND USING THE SAME |
WO2013159055A1 (en) | 2012-04-20 | 2013-10-24 | Codexis, Inc. | Production of fatty alcohols from engineered microorganisms |
CA2947212A1 (en) | 2014-05-26 | 2015-12-03 | Scientist Of Fortune S.A. | Method for the enzymatic production of d-erythrose and acetyl phosphate |
US11274286B2 (en) | 2018-07-09 | 2022-03-15 | Codexis, Inc. | Engineered deoxyribose-phosphate aldolases |
-
2019
- 2019-07-02 US US16/460,118 patent/US11274286B2/en active Active
- 2019-07-02 KR KR1020217003782A patent/KR20210032417A/ko unknown
- 2019-07-02 CA CA3103721A patent/CA3103721A1/en active Pending
- 2019-07-02 CN CN201980057974.4A patent/CN112673105A/zh active Pending
- 2019-07-02 MX MX2021000326A patent/MX2021000326A/es unknown
- 2019-07-02 JP JP2021500435A patent/JP7462969B2/ja active Active
- 2019-07-02 AU AU2019300836A patent/AU2019300836A1/en active Pending
- 2019-07-02 SG SG11202012107RA patent/SG11202012107RA/en unknown
- 2019-07-02 WO PCT/US2019/040369 patent/WO2020014048A1/en active Application Filing
- 2019-07-02 EP EP19833390.8A patent/EP3821015A4/en active Pending
-
2020
- 2020-12-30 IL IL279882A patent/IL279882A/en unknown
-
2022
- 2022-02-04 US US17/592,869 patent/US11845968B2/en active Active
-
2023
- 2023-11-07 US US18/503,542 patent/US20240076647A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3821015A1 (en) | 2021-05-19 |
EP3821015A4 (en) | 2022-07-13 |
IL279882A (en) | 2021-03-01 |
JP2021530980A (ja) | 2021-11-18 |
CA3103721A1 (en) | 2020-01-16 |
WO2020014048A1 (en) | 2020-01-16 |
US20240076647A1 (en) | 2024-03-07 |
KR20210032417A (ko) | 2021-03-24 |
US11274286B2 (en) | 2022-03-15 |
US11845968B2 (en) | 2023-12-19 |
CN112673105A (zh) | 2021-04-16 |
US20200010868A1 (en) | 2020-01-09 |
SG11202012107RA (en) | 2021-01-28 |
AU2019300836A1 (en) | 2021-01-07 |
US20220162580A1 (en) | 2022-05-26 |
JP7462969B2 (ja) | 2024-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021000326A (es) | Desoxirribosa-fosfato aldolasas modificadas geneticamente. | |
PH12017500861A1 (en) | Anti-interleukin-33 antibodies and uses thereof | |
MX2019006539A (es) | Sistemas y metodos para la extraccion de productos naturales. | |
CR20230163A (es) | ANTICUERPOS ANTITAU Y MÉTODOS DE USO (Divisional 2019-0271) | |
PH12018500268A1 (en) | 2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridins as bace1 inhibitors | |
WO2018106776A3 (en) | Anti-tau antibodies and methods of their use | |
MX2016013216A (es) | Dispositivos mejorados para la separacion de materiales biologicos. | |
MX2019011423A (es) | Metodos de tratamiento de enfermedades neurodegenerativas. | |
PH12018550160A1 (en) | NEW ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS | |
MX2019010769A (es) | Proceso para la preparacion de enlazadores de farmacos de glucuronidos y compuestos intermediarios de los mismos. | |
PH12019501872A1 (en) | Anti-tryptase antibodies, compositions thereof, and uses thereof | |
MX2015013419A (es) | Cianoetilpirazolo piridonas aciclicas como inhibidores de janus quinasa. | |
NZ730250A (en) | 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as sgrm modulators | |
EP3580185A4 (en) | SLUDGE TREATMENT PROCESS | |
WO2018162557A3 (en) | Method for purifying proteins using silicate | |
EP4001310A3 (en) | Ion channel modulators and uses thereof | |
MX2021012984A (es) | Anticuerpos y metodos para el tratamiento de la infeccion por influenza a. | |
MX2019004182A (es) | Proceso para la fabricacion de 2,6-dimetil-5-hepten-1-al. | |
MY184366A (en) | Pyrazines modulators of gpr6 | |
SE1750819A1 (sv) | A vertical lime kiln | |
MX2022011897A (es) | Composicion intraarticular para el tratamiento del cartilago y la artritis. | |
MX2020004093A (es) | Puzolana de vidrio activada. | |
IN2014MU00626A (es) | ||
HUP1700296A2 (hu) | Biológiai eredetû hulladékanyag massza közvetlen elégetésére szánt tüzelõanyag gyártására és biológiai eredetû hulladékanyagból tüzelõanyag elõállítási módszer | |
MX2021003888A (es) | Nuevos compuestos utiles para el tratamiento de enfermedades cardiovasculares. |